A clinical trial to compare SGI-110 to other available treatments in patients with previously untreated Acute Myeloid Leukemia(AML) who are not considered suitable for intensive Chemotherapy

Update Il y a 4 ans
Reference: EUCTR2014-001233-89

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess and compare efficacy (complete response [CR] rate) and overall survival (OS) between SGI-110 and TC (treatment choice) in adults with previously untreated AML who are not considered candidates for intensive remission induction chemotherapy.


Inclusion criteria

  • Acute Myeloid Leukemia (AML)